Do not take mucosal biopsies when the histopathological results would not change the patient management.

Do not use single use endoscopes regularly as they should be reserved for highly selected patients, on a case-by-case basis (immunocompromised patients or those with multidrug-resistant bacteria).

In most studies the calculated minimum estimated endoscope-associated infection risk is low when reprocessing protocols are correctly applied. The carbon footprint of single-use endoscopes is substantial as recent studies estimates that releases of CO2 and consumes of...
Do not take mucosal biopsies when the histopathological results would not change the patient management.

Do not abuse of periprocedural and intraprocedural medication and prefer their use only when strictly indicated (e.g. avoid inadequate antibiotic prophylaxis and saline fluid intravenous solution)

The environmental burden of medications before endoscopy (bowel preparation and laxatives for colonoscopy, or mucolytic solutions), during (sedatives, antibiotics, or analgesics), and after the procedure has not been formally quantified but it has recently been...
Don’t recommend a test, a treatment or a procedure that will not change the patient clinical course; do not hesitate to ask your tutor for clarification if you believe that those tests, treatment or procedures are not necessary and always opt for less invasive options.

Don’t recommend a test, a treatment or a procedure that will not change the patient clinical course; do not hesitate to ask your tutor for clarification if you believe that those tests, treatment or procedures are not necessary and always opt for less invasive options.

The administration of tests, treatment or procedures might not change the patient management plan for many reasons. In some cases, the pre-test probability of a patient for a certain condition is low and further testing might not be necessary (e.g. brest cancer...